BioPharmSignal logoBioPharmSignal

Biotech News

Privia Health Reports Third Quarter 2025 Financial Results

Privia Health (PRVA)Privia HealthEarnings

Very Strong Third Quarter and Year-to-Date Performance Across the Business Net Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q’24 Implemented Providers +13.1% and Practice Collections +27.1% compared to 3Q’24 FY’25 Guidance Raised Above High End for All Key Operating and Financial Metrics

Related news

PRVAPrivia Health2026-05-07 10:00 EST

Privia Health Reports First Quarter 2026 Financial Results

PRVAPrivia Health2026-02-26 11:00 EST

Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results

View all latest news

Privia Health

Physician Enablement Platform Privia Health supports independent physicians with technology and services that allow practices to remain physician-led while operating within scaled medical groups. Provider Networks The company builds primary-care-centered provider networks, risk-bearing entities and local medical groups with shared...

Recent company news

PRVAPrivia Health2026-08-18 13:00 EST

Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors

PRVAPrivia Health2026-08-06 10:00 EST

Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results

PRVAPrivia Health2026-07-07 13:00 EST

Privia Health to Report Second Quarter 2026 Results on Thursday, August 6

PRVAPrivia Health2026-05-27 13:00 EST

Privia Health Enters New Jersey

PRVAPrivia Health2026-05-07 10:00 EST

Privia Health Reports First Quarter 2026 Financial Results

Stock data

Close
21.50 USD
Market cap
2.62B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States